中国疫苗百姓不敢打

12月17日，据《南华早报》报导，由中国国药集团(Sinopharm)和北京科兴控股生物技术有限公司（Sinovac）制造的灭活疫苗，将开始对中国各地分发。

当局要求疫苗要在中国新年假期前结束施打，第一阶段五千万剂的疫苗，要求在明年1月15日前施打完毕，第二阶段要在2月5日前完成。

当局规定，预防性疫苗不纳入医保支付范围，需自费接种。疫苗价格昂贵，且各地收费不一。武汉一位社区义工陈女士对自由亚洲透露，当地接种疫苗收费一次2700元一针，要打3针，共计8千多元人民币。

陈女士说，武汉很多居民想注射疫苗但钱不够，都在期待疫苗降价。但也有很多人担心疫苗安全问题，不愿接种。

陈女士透露，有内部人员叫她别打，让她再等一下。“他们临床试验还是时间不长，所以他们（医生）让我先别打。”

《金融时报》12月16日刊文称，现在中国研制的中共病毒疫苗，没有一款走完研制程序，而且有的疫苗连第一阶段动物实验的数据都没有公布，就进入人体临床试验阶段，质疑中国疫苗后续恐出现问题。

北京毒奶粉受害儿童家长郭利说，民众对疫苗质量的担心是有根据的，“风险非常大。”

广州居民赵先生表示，有社区人员提供免费中共病毒疫苗，但他不敢接种。

上海一英资公司高管谢丽娟透露，现在这个疫苗是在中国内部，官员，还包括医疗机构内部在打。

谢丽娟说，“听我妹妹讲，我妹在医疗机构，她说医院让他们报名注射疫苗，但医院没人敢报名，都不想打。因为第一批疫苗不知道安全性怎么样。”

之前上海官方对医院工作人员摸底，拒绝接种的医护人员比例高达93.4%。

中国疫苗爆出严重事故

事实上，中国疫苗在临床试验中就已经爆出严重事故。巴西国家卫生监督局（Anvisa）11月9日表示，已暂停北京科兴疫苗的临床试验，原因是疫苗受试者在10月29日发生“严重不良反应”。

据巴西CBN广播电台（Central Brasileira de Notícias）披露，事故导致了志愿者死亡，去世者死因不明。但北京科兴否认受试者出现“严重不良反应”与疫苗有关。

11月1日，成千上万巴西民众聚集在圣保罗主要商业街抗议，示威者手持写着“我们不是白老鼠”、“不要疫苗”标语。

中国工人打疫苗 感染病毒

虽然中国疫苗并未通过验证，但早在一个月前，浙江嘉兴疾控中心就对外宣称，浙江有一百多万人已经接种了尚在研发过程中的中共病毒疫苗。

另外，根据中共官方消息，从6月起出国的人员，特别是中央直属企业境外派驻的务工人员已开始接种疫苗。但已经出现数量众多的接种者感染，引发国际社会对中国疫苗的恐慌。

自由亚洲电台12月15日引述消息说，4天前，安哥拉当地传出至少17名中国人被感染，其中16人都是位于北隆达省的一家中资国企的职工。他们在出国之前都已统一接种了“国药集团”研发的中共病毒疫苗。

报导还引述来自塞尔维亚的消息说，天津电力建设公司在该国潘切沃的一个项目部里，400多名员工中约300人已经确诊中共肺炎。当中包括大批来自国内的员工，他们事先也已经接种了“国药集团”的中共病毒疫苗。

12月5日，中共驻乌干达大使馆曾公告说，47名中国工人在乌干达发生中共病毒聚集性感染。他们应当也接种过中国疫苗。

中国疫苗恐引发病毒大爆发

前美国哈佛大学公共卫生学院教授李敦厚曾指出，中国生产的灭活疫苗，在生产过程中非常具有挑战性，很难保证不出现安全隐患。

李敦厚直言，自己肯定不会打中国生产的疫苗。

台湾防疫专家日前也明确表示，台湾不会研发灭活疫苗，也不会接种灭活疫苗。

今年年初，中共隐瞒疫情，导致病毒全球泛滥，祸害全世界。如今，美、英等国研发出中共病毒疫苗，中共为抢占疫苗市场，将尚未研制成功、存在安全隐患的疫苗给中国民众施打，甚至出口至其他国家。舆论谴责，中共此举无异于是第二次散毒，恐再度引发疫情全球大爆发。

Schematic diagram of the CCP virus vaccine. (Image by Bao_5 from Pixabay)   

Communist authorities plan to vaccinate 50 million Chinese people against the Chinese Communist virus before the Chinese New Year holiday. However, the vaccines developed in China are not only expensive, but none of them have passed the final qualification test. Experts are concerned that the authorities' focus on collecting money to vaccinate people on a large scale will increase safety risks and could lead to serious consequences.

Chinese vaccine people dare not play

On December 17, the South China Morning Post reported that inactivated vaccines manufactured by Sinopharm and Beijing Kexing Holdings Biotechnology Co.

Authorities require the vaccine to be administered before the Chinese New Year holiday, with the first phase of 50 million doses to be administered by Jan. 15 next year and the second phase to be completed by Feb. 5.

The authorities stipulate that preventive vaccines are not covered by health insurance and must be administered at one's own expense. The vaccine is expensive and charges vary from place to place. Ms. Chen, a community volunteer in Wuhan, told Free Asia that the local vaccination fee is 2,700 yuan for one shot, and three shots are required, totaling more than 8,000 yuan.

Ms. Chen said that many residents in Wuhan want to be vaccinated but don't have enough money, and are expecting the price of the vaccine to drop. But there are also many people who are worried about the safety of the vaccine and are reluctant to receive it.

Ms. Chen revealed that some insiders told her not to get the shot and to wait a little longer. "They still don't have a long time for clinical trials, so they (doctors) told me not to fight first."

The Financial Times published an article on December 16, saying that none of the CCP virus vaccines developed in China now have gone through the development process, and some vaccines have not even released data from the first phase of animal experiments before entering the human clinical trial stage, questioning the fear of problems with the follow-up of Chinese vaccines.

Guo Li, a parent of a child victim of tainted milk powder in Beijing, said the public's fears about the quality of vaccines are well-founded and that "the risks are very high."

Mr. Zhao, a Guangzhou resident, said there are community members offering free vaccines against the Chinese Communist virus, but he is afraid to get them.

Xie Lijuan, an executive at a British-owned company in Shanghai, revealed that the vaccine is now being administered within China, by officials, and also within medical institutions.

Xie Lijuan said, "I heard from my sister, who is in a medical institution, she said the hospital let them sign up for the vaccine, but no one in the hospital dared to sign up, they didn't want to do it. Because the first batch of vaccines don't know how safe it is."

Previously, Shanghai officials mapped hospital staff and the percentage of health care workers who refused vaccination was as high as 93.4 percent.

Chinese vaccines explode in serious accidents

In fact, the Chinese vaccine has already been the subject of serious accidents in clinical trials. Brazil's National Health Surveillance Agency (Anvisa) said on Nov. 9 that it had suspended clinical trials of the Beijing Kexing vaccine because of "serious adverse reactions" in vaccine subjects on Oct. 29.

According to Brazilian radio station CBN (Central Brasileira de Notícias), the accident resulted in the death of the volunteer, whose cause of death was unknown. However, Beijing KeXing denied that the "serious adverse reactions" in the subjects were related to the vaccine.

On Nov. 1, thousands of Brazilians gathered in the main shopping street of São Paulo to protest, holding signs that read "We are not white mice" and "No vaccines.

Chinese workers vaccinated, infected with virus

Although the Chinese vaccine has not been validated, as early as a month ago, the Jiaxing CDC in Zhejiang Province claimed that more than one million people in Zhejiang had been vaccinated against the Communist virus, which is still in the process of development.

In addition, according to official Communist Party sources, people who have left the country since June, especially workers posted outside the country by central government-affiliated enterprises, have been vaccinated. However, a large number of vaccinated people have already been infected, sparking international fears about the Chinese vaccine.

Cited by Radio Free Asia on December 15, the source said that four days ago, at least 17 Chinese were reported to have been infected in Angola, 16 of whom were employees of a Chinese-owned state-owned enterprise in Lunda Norte province. They had all been vaccinated against the Chinese Communist virus developed by the Sinopharm Group before leaving the country.

The report also quoted sources from Serbia as saying that about 300 of the more than 400 employees at a Tianjin Power Construction Company project in Pančevo, China, have been diagnosed with Chinese Communist pneumonia. Among them were a large number of employees from China, who had also been vaccinated against the CCP virus by Sinopharm.

On December 5, the Chinese Embassy in Uganda announced that 47 Chinese workers had been infected with the CCP virus in Uganda. They should also have received the Chinese vaccine.

Chinese Vaccine Fears Outbreak of Virus

Former Harvard School of Public Health professor Dunhou Li has pointed out that the inactivated vaccines produced in China are very challenging to produce and it is difficult to ensure that there are no safety hazards.

Lee said outright that he would definitely not give the vaccine produced in China.

Taiwan's epidemic prevention experts also made it clear recently that Taiwan will not develop inactivated vaccines and will not be vaccinated with inactivated vaccines.

Earlier this year, the Chinese Communist Party concealed the epidemic, which led to the global spread of the virus and the scourge of the world. Now, the United States, Britain and other countries have developed vaccines for the Chinese Communist Party's virus. In order to seize the vaccine market, the Chinese Communist Party has given the Chinese people vaccines that have not yet been successfully developed and have safety risks, and even exported them to other countries. Public opinion condemns this move by the Chinese Communist Party as a second spread of the virus, threatening to trigger another global outbreak of the disease.